103 related articles for article (PubMed ID: 16682940)
1. Effects of thyroxine withdrawal in biochemical parameters and cardiac function and structure in patients with differentiated thyroid cancer.
Chrisoulidou A; Pazaitou-Panayiotou K; Kaprara A; Platoyiannis D; Lafaras C; Boudina M; Georgiou E; Drimonitis A; Bischiniotis T; Vainas I
Minerva Endocrinol; 2006 Jun; 31(2):173-8. PubMed ID: 16682940
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
3. Changes in biochemical parameters during complete thyroid hormone deficiency of short duration in athyreotic patients.
Weissel M; Kainz H; Höfer R
J Nucl Med; 1986 Oct; 27(10):1528-32. PubMed ID: 3760976
[TBL] [Abstract][Full Text] [Related]
4. Short-term overt hypothyroidism induces discrete diastolic dysfunction in patients treated for differentiated thyroid carcinoma.
Hoftijzer HC; Bax JJ; Heemstra KA; Bleeker GB; Delgado V; van der Klaauw AA; Romijn JA; Smit JW; Corssmit EP
Eur J Clin Invest; 2009 Mar; 39(3):204-10. PubMed ID: 19260950
[TBL] [Abstract][Full Text] [Related]
5. Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
Papadakis G; Kalaitzidou S; Triantafillou E; Drosou A; Kakava K; Dogkas N; Pappa T; Kaltzidou V; Tertipi A; Villiotou V; Pappas A
Anticancer Res; 2015 Dec; 35(12):6933-40. PubMed ID: 26637919
[TBL] [Abstract][Full Text] [Related]
6. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
7. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
Botella-Carretero JI; Gómez-Bueno M; Barrios V; Caballero C; García-Robles R; Sancho J; Escobar-Morreale HF
Endocr Relat Cancer; 2004 Jun; 11(2):345-56. PubMed ID: 15163309
[TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
9. [Treatment with L-thyroxine for differentiated thyroid carcinoma].
Łacka K
Wiad Lek; 2001; 54 Suppl 1():368-72. PubMed ID: 12182051
[TBL] [Abstract][Full Text] [Related]
10. Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer.
Regalbuto C; Alagona C; Maiorana R; Di Paola R; Cianci M; Alagona G; Sapienza S; Vigneri R; Pezzino V
J Endocrinol Invest; 2006 Jan; 29(1):32-40. PubMed ID: 16553031
[TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
[TBL] [Abstract][Full Text] [Related]
12. Comparison of conventional L-thyroxine withdrawal and moderate hypothyroidism in preparation for whole-body 131-I scan and thyroglobulin testing.
Marturano I; Russo M; Spadaro A; Latina A; Malandrino P; Regalbuto C
J Endocrinol Invest; 2015 Sep; 38(9):1017-22. PubMed ID: 26070652
[TBL] [Abstract][Full Text] [Related]
13. Three-week thyroxine withdrawal: a thyroid-specific quality of life study.
Davids T; Witterick IJ; Eski S; Walfish PG; Freeman JL
Laryngoscope; 2006 Feb; 116(2):250-3. PubMed ID: 16467714
[TBL] [Abstract][Full Text] [Related]
14. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.
Pötzi C; Moameni A; Karanikas G; Preitfellner J; Becherer A; Pirich C; Dudczak R
Clin Endocrinol (Oxf); 2006 Oct; 65(4):519-23. PubMed ID: 16984246
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
16. [Response of thyroglobulin, anti-thyroglobulin antibodies, TSH, FT4 and total T3 after rhTSH stimulation in differentiated thyroid carcinoma].
Moreno Ortega E; Vallejo Casas JA; Mena Bares LM; del Real Núñez R; Maza Muret FR; Hidalgo Ramos FJ; Latre Romero JM
Rev Esp Med Nucl; 2008; 27(4):253-8. PubMed ID: 18682151
[TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
18. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
[TBL] [Abstract][Full Text] [Related]
19. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
[TBL] [Abstract][Full Text] [Related]
20. In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin.
Valle LA; Gorodeski Baskin RL; Porter K; Sipos JA; Khawaja R; Ringel MD; Kloos RT
Thyroid; 2013 Feb; 23(2):185-93. PubMed ID: 22978687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
